Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V8MD
|
||||
| Former ID |
DNC003651
|
||||
| Drug Name |
8-PHENYL THEOPHYLLINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530590] | ||
| Formula |
C13H12N4O2
|
||||
| Canonical SMILES |
CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC=CC=C3
|
||||
| InChI |
1S/C13H12N4O2/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)8-6-4-3-5-7-8/h3-7H,1-2H3,(H,14,15)
|
||||
| InChIKey |
PJFMAVHETLRJHJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530590] | |
| Adenosine A2b receptor | Target Info | Inhibitor | [525962] | ||
| Adenosine A1 receptor | Target Info | Inhibitor | [530590] | ||
| Adenosine A3 receptor | Target Info | Inhibitor | [533542] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Parkinson's disease | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addiction | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
| References | |||||
| Ref 525962 | J Med Chem. 2001 Jan 18;44(2):170-9.2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor. | ||||
| Ref 530590 | J Med Chem. 1991 Mar;34(3):1202-6.1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists. | ||||
| Ref 533542 | J Med Chem. 1982 Mar;25(3):197-207.Adenosine receptors: targets for future drugs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.